(MENAFNEditorial) Denver, Colorado, Dec. 19, 2017 (GLOBE NEWSWIRE) -- Cann10, one of the leaders in global medical cannabis, trade, professional education and events is pleased to announce the opening of Cann10 North America. Incorporated in BC, Canada, Cann10 NA will serve the growing needs of the North American Cannabis Community while opening new opportunities for Cann10 worldwide.
Cann10 continually explores new trade opportunities to fill the expanding needs of the cannabis markets in Canada, USA, Europe and around the world.
Cann10 North America will be involved in:
- Expanding Trade and Business Activities
- Offering Medical Cannabis Education and Courses
- Offering new Investment Opportunities
- Running the industry's premiere Medical Cannabis Industry Conferences
Cann10 North America will create new learning programs for Universities and organizations building on the work already done in Australia, Israel and other countries. Cann10 North America will give investors the opportunity to intelligently invest in an industry that is growing rapidly but is still clouded in mystery. Cann10 North America will offer advanced R & D and technologies from Israel in addition to seeking new technologies in Canada and the USA, for global markets.
Yossi Bornstein, Chairman of Cann10 International, stated that' North America is a strategic market for us. Medical Cannabis is a serious business and we are now involved in the world's fastest growing market. We have existing partnerships with farms, production facilities, R & D and educational activities in more than a dozen countries.' continued Mr. Bornstein. 'Now we can bring this experience to the North American market. We are the only global organization that understands what is involved at every stage of the business, from education, to cultivation, to dispensary and the end-user.'
The list of priorities for Cann10 North America includes finding new trade opportunities for the Cann10 worldwide network while developing one of the leading Medical Cannabis Industry Conference in 2019 for North America. This includes building educational programs in North America like those held in conjunction with Australia's Deakin University and Israel's Technion. These programs are targeted at medical professional, pharmacists, caregivers, nurses and entrepreneurs.
Cann10 is a medical cannabis focused accelerator, offering selected entrepreneurs the advantages of high quality infrastructures, facilities, team, network, know-how and professional mentoring, tailored to support successful development, fund raising and commercialization of new technologies in this emerging field.
A collaboration between a leading Israeli authorized medical cannabis farm, and a leading Israeli holding and services group, Cann10 combines the respective expertise in the fields of medical cannabis and commercialization of medical devices and drugs, to support the introduction of new high value related products.
Cann10 has the accredited infrastructure and know-how in the medical cannabis and Med Tech industries, and a strong seasoned and well-connected management team
Office: Cann10 (Shizim Group) Tel: +972-3-9002025 Email:
22 Hamelacha St. P.O. Box 11372, Rosh Ha'ayin, 4809169 Israel
For more information, please contact Ofer Spottheim at Cann10 -
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.